Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-006027
Filing Date
2016-05-16
Accepted
2016-05-16 16:13:08
Documents
75
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q aegr-20160331x10q.htm 10-Q 2087540
2 EX-10.1 aegr-20160331ex101fc8006.htm EX-10.1 35140
3 EX-10.2 aegr-20160331ex102a5f962.htm EX-10.2 27051
4 EX-10.3 aegr-20160331ex1033e9e56.htm EX-10.3 68686
5 EX-31.1 aegr-20160331ex31185afe4.htm EX-31.1 12218
6 EX-31.2 aegr-20160331ex312a55bee.htm EX-31.2 11915
7 EX-32.1 aegr-20160331ex321e25a0a.htm EX-32.1 8586
8 EX-32.2 aegr-20160331ex3228bb88d.htm EX-32.2 8150
9 GRAPHIC aegr20160331ex101fc8006001.jpg GRAPHIC 9418
  Complete submission text file 0001558370-16-006027.txt   7142425

Data Files

Seq Description Document Type Size
10 EX-101.INS aegr-20160331.xml EX-101.INS 1461732
11 EX-101.SCH aegr-20160331.xsd EX-101.SCH 43404
12 EX-101.CAL aegr-20160331_cal.xml EX-101.CAL 57812
13 EX-101.DEF aegr-20160331_def.xml EX-101.DEF 124822
14 EX-101.LAB aegr-20160331_lab.xml EX-101.LAB 361881
15 EX-101.PRE aegr-20160331_pre.xml EX-101.PRE 298995
Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Filer) CIK: 0001338042 (see all company filings)

EIN.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34921 | Film No.: 161653908
SIC: 2834 Pharmaceutical Preparations